Difficulty: Medium
Average Score: 78%
Practice
Hemophilia A is characterized by:
Correct answer
C
Rationale
In hemophilia A, which is a genetic disorder caused by a deficiency in clotting factor VIII, the correct answer is C) Prolonged APPT (Activated Partial Thromboplastin Time). This is because hemophilia A specifically affects the intrinsic pathway of the coagulation cascade, leading to a prolonged APPT due to the deficiency of factor VIII.
Option A) Prolonged bleeding time is incorrect because bleeding time primarily assesses platelet function, not the clotting factors affected in hemophilia A.
Option B) Prolonged prothrombin time is incorrect because prothrombin time evaluates the extrinsic pathway of the coagulation cascade, which is not primarily affected in hemophilia A.
Option D) Prolonged thrombin time is incorrect because thrombin time measures the conversion of fibrinogen to fibrin, which is not directly impacted in hemophilia A.
Educationally, understanding the specific clotting factors involved in hemophilia A and how they affect different parts of the coagulation pathway is crucial for nurses caring for pediatric patients with this condition. Recognizing the unique laboratory findings in hemophilia A can guide appropriate treatment strategies and interventions to prevent bleeding complications in these patients.
Option A) Prolonged bleeding time is incorrect because bleeding time primarily assesses platelet function, not the clotting factors affected in hemophilia A.
Option B) Prolonged prothrombin time is incorrect because prothrombin time evaluates the extrinsic pathway of the coagulation cascade, which is not primarily affected in hemophilia A.
Option D) Prolonged thrombin time is incorrect because thrombin time measures the conversion of fibrinogen to fibrin, which is not directly impacted in hemophilia A.
Educationally, understanding the specific clotting factors involved in hemophilia A and how they affect different parts of the coagulation pathway is crucial for nurses caring for pediatric patients with this condition. Recognizing the unique laboratory findings in hemophilia A can guide appropriate treatment strategies and interventions to prevent bleeding complications in these patients.